Telix Pharmaceuticals Ltd (TLX) insider trading
Every open-market stock purchase and sale by Telix Pharmaceuticals Ltd executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders bought $997K over the last 12 months (1 buy).
- Last insider buy: Christian Behrenbruch (CEO), $497K, 5 months ago.
Last 12 months: insiders bought $997K (1 buy) and sold $0 (0 sales).
Recent TLX insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Apr 29, 2026 | Christian Behrenbruch (CEO) | Bought | $497K |
| Apr 28, 2026 | Christian Behrenbruch (CEO) | Bought | $500K |
| Mar 29, 2026 | Darren Charlton Smith (CFO) | Bought (not open market) | — |
Who's trading TLX
- Christian Behrenbruch, CEO: bought $997K (2 buys), last Apr 29, 2026
- Darren Charlton Smith, CFO: other filings, last Mar 29, 2026
Get free alerts when an insider at Telix Pharmaceuticals Ltd files a new trade →